Wild-type p53 inhibits replication-associated homologous recombination
- PMID: 12185593
- DOI: 10.1038/sj.onc.1205757
Wild-type p53 inhibits replication-associated homologous recombination
Abstract
In mammalian cells homologous recombination is stimulated, when the replication fork stalls at DNA breaks or unrepaired lesions. The tumor suppressor p53 downregulates homologous recombination independently of its transcriptional transactivation function and has been linked to enzymes of DNA recombination and replication. To study recombination with respect to replication, we utilized a SV40 virus based assay, to follow the synchronous events after primate cell infection. gamma-ray treatment at different times after viral entry unveiled an increase of interchromosomal exchange frequencies, when the damage was introduced during DNA synthesis. Elevated recombination frequencies were fully suppressed by p53. With respect to the downregulation of spontaneous recombination, we noticed a requirement for active p53 molecules, when replication started. After a transient treatment with replication inhibitors, we observed inhibition of the drug induced recombination by p53, particularly for the elongation inhibitor aphidicolin. Consequently, we propose that p53 is a surveillance factor of homologous recombination at replication forks, when they stall as a consequence of endogenous or of exogenously introduced damage.
Similar articles
-
Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.Oncogene. 2002 Jan 17;21(3):488-92. doi: 10.1038/sj.onc.1205040. Oncogene. 2002. PMID: 11821962
-
BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination.EMBO J. 2003 Mar 3;22(5):1210-22. doi: 10.1093/emboj/cdg114. EMBO J. 2003. PMID: 12606585 Free PMC article.
-
p53 protects from replication-associated DNA double-strand breaks in mammalian cells.Oncogene. 2004 Mar 25;23(13):2324-9. doi: 10.1038/sj.onc.1207379. Oncogene. 2004. PMID: 14743204
-
p53 in recombination and repair.Cell Death Differ. 2006 Jun;13(6):1003-16. doi: 10.1038/sj.cdd.4401903. Cell Death Differ. 2006. PMID: 16543940 Review.
-
SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication.Bioessays. 1993 Feb;15(2):121-7. doi: 10.1002/bies.950150208. Bioessays. 1993. PMID: 8385943 Review.
Cited by
-
Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.Oncotarget. 2021 Jun 8;12(12):1128-1146. doi: 10.18632/oncotarget.27975. eCollection 2021 Jun 8. Oncotarget. 2021. PMID: 34136083 Free PMC article.
-
Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation.BMC Pulm Med. 2021 Oct 11;21(1):316. doi: 10.1186/s12890-021-01671-8. BMC Pulm Med. 2021. PMID: 34635074 Free PMC article.
-
Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers.Front Oncol. 2018 Aug 8;8:303. doi: 10.3389/fonc.2018.00303. eCollection 2018. Front Oncol. 2018. PMID: 30135856 Free PMC article. Review.
-
p53 null fluorescent yellow direct repeat (FYDR) mice have normal levels of homologous recombination.DNA Repair (Amst). 2011 Dec 10;10(12):1294-9. doi: 10.1016/j.dnarep.2011.09.009. Epub 2011 Oct 12. DNA Repair (Amst). 2011. PMID: 21993421 Free PMC article.
-
RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2136-2147. doi: 10.1158/1055-9965.EPI-22-0590. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36129803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
